Agilon Health (AGL) Competitors $1.70 -0.10 (-5.31%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$1.73 +0.03 (+2.06%) As of 08/1/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AGL vs. SGRY, CON, WGS, PRVA, ADUS, PGNY, VCYT, PACS, LFST, and ARDTShould you be buying Agilon Health stock or one of its competitors? The main competitors of Agilon Health include Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), GeneDx (WGS), Privia Health Group (PRVA), Addus HomeCare (ADUS), Progyny (PGNY), Veracyte (VCYT), PACS Group (PACS), LifeStance Health Group (LFST), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry. Agilon Health vs. Its Competitors Surgery Partners Concentra Group Holdings Parent GeneDx Privia Health Group Addus HomeCare Progyny Veracyte PACS Group LifeStance Health Group Ardent Health Surgery Partners (NASDAQ:SGRY) and Agilon Health (NYSE:AGL) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment. Which has more volatility and risk, SGRY or AGL? Surgery Partners has a beta of 1.82, indicating that its share price is 82% more volatile than the S&P 500. Comparatively, Agilon Health has a beta of 0.14, indicating that its share price is 86% less volatile than the S&P 500. Is SGRY or AGL more profitable? Agilon Health has a net margin of -4.04% compared to Surgery Partners' net margin of -6.10%. Surgery Partners' return on equity of 2.41% beat Agilon Health's return on equity.Company Net Margins Return on Equity Return on Assets Surgery Partners-6.10% 2.41% 0.99% Agilon Health -4.04%-45.47%-12.76% Which has better earnings & valuation, SGRY or AGL? Surgery Partners has higher earnings, but lower revenue than Agilon Health. Surgery Partners is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgery Partners$3.11B0.88-$168.10M-$1.53-13.91Agilon Health$6.06B0.12-$260.15M-$0.59-2.87 Do analysts prefer SGRY or AGL? Surgery Partners currently has a consensus price target of $33.33, indicating a potential upside of 56.64%. Agilon Health has a consensus price target of $4.71, indicating a potential upside of 178.13%. Given Agilon Health's higher probable upside, analysts clearly believe Agilon Health is more favorable than Surgery Partners.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surgery Partners 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70Agilon Health 2 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.17 Does the media favor SGRY or AGL? In the previous week, Surgery Partners had 6 more articles in the media than Agilon Health. MarketBeat recorded 11 mentions for Surgery Partners and 5 mentions for Agilon Health. Surgery Partners' average media sentiment score of 0.66 beat Agilon Health's score of -0.24 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 3 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilon Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummarySurgery Partners beats Agilon Health on 9 of the 14 factors compared between the two stocks. Get Agilon Health News Delivered to You Automatically Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGL vs. The Competition Export to ExcelMetricAgilon HealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$703.72M$7.13B$5.53B$20.47BDividend YieldN/A2.89%4.74%3.71%P/E Ratio-2.8715.6119.2826.72Price / Sales0.1234.05440.8757.15Price / CashN/A25.3535.0722.46Price / Book1.498.618.254.43Net Income-$260.15M$239.96M$3.25B$993.74M7 Day Performance-17.92%-5.48%-3.73%-3.39%1 Month Performance-28.78%-3.73%4.28%-2.10%1 Year Performance-73.24%18.27%25.85%10.09% Agilon Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGLAgilon Health1.6065 of 5 stars$1.70-5.3%$4.71+178.1%-74.2%$703.72M$6.06B-2.871,076Upcoming EarningsSGRYSurgery Partners2.9321 of 5 stars$22.44+5.6%$33.33+48.5%-29.6%$2.88B$3.17B-14.6715,000Upcoming EarningsCONConcentra Group Holdings Parent2.8957 of 5 stars$20.05+2.0%$28.50+42.1%-14.0%$2.57B$1.93B14.9611,250Upcoming EarningsWGSGeneDx3.0013 of 5 stars$84.91+6.4%$92.33+8.7%+215.0%$2.42B$305.45M-60.221,200News CoverageEarnings ReportAnalyst ForecastInsider TradeOptions VolumeGap DownPRVAPrivia Health Group3.901 of 5 stars$19.70-0.1%$28.38+44.1%-8.0%$2.40B$1.74B164.181,140Upcoming EarningsADUSAddus HomeCare4.8879 of 5 stars$109.11-0.3%$142.57+30.7%-13.9%$2.01B$1.21B24.6349,703Positive NewsUpcoming EarningsPGNYProgyny2.0174 of 5 stars$23.20+0.4%$24.82+7.0%-17.0%$1.99B$1.21B40.70310Positive NewsUpcoming EarningsVCYTVeracyte2.9037 of 5 stars$25.02-0.9%$40.90+63.5%+3.0%$1.96B$463.39M61.03790Positive NewsUpcoming EarningsHigh Trading VolumePACSPACS Group3.1029 of 5 stars$11.83+1.2%$34.29+189.8%-70.3%$1.80B$3.11B0.0032,433News CoveragePositive NewsLFSTLifeStance Health Group3.1752 of 5 stars$4.17+0.7%$8.42+101.8%-32.4%$1.62B$1.25B-41.7010,218News CoverageUpcoming EarningsARDTArdent Health3.7301 of 5 stars$10.67-3.5%$20.30+90.3%-43.2%$1.53B$6.02B6.5524,900Upcoming Earnings Related Companies and Tools Related Companies Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives GeneDx Alternatives Privia Health Group Alternatives Addus HomeCare Alternatives Progyny Alternatives Veracyte Alternatives PACS Group Alternatives LifeStance Health Group Alternatives Ardent Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AGL) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agilon Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agilon Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
